MARC details
| 000 -LEADER |
|---|
| fixed length control field |
04944cam a2200589 i 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
ocn837578458 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OCoLC |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20221128212208.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION |
|---|
| fixed length control field |
m d |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
|---|
| fixed length control field |
cr ||||||||||| |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
120402s2012 nyua ob 001 0 eng |
| 010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
|---|
| LC control number |
2019714376 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
DLC |
| 019 ## - |
|---|
| -- |
923664914 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| ISBN |
9781620816295 |
| Qualifying information |
ebook |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| ISBN |
1620816296 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| Cancelled/invalid ISBN |
9781620815809 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| Cancelled/invalid ISBN |
162081580X |
| Qualifying information |
(hbk.) |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
541277 |
| -- |
(N$T) |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
(OCoLC)837578458 |
| Canceled/invalid control number |
(OCoLC)923664914 |
| 042 ## - AUTHENTICATION CODE |
|---|
| Authentication code |
pcc |
| 060 #4 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
|---|
| Classification number |
WJ 300 |
| 072 #7 - SUBJECT CATEGORY CODE |
|---|
| Subject category code |
MED |
| Subject category code subdivision |
055000 |
| Source |
bisacsh |
| 049 ## - LOCAL HOLDINGS (OCLC) |
|---|
| Holding library |
MAIN |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Nephropathy : |
| Subtitle |
diagnosis and treatment |
| Statement of responsibility, etc |
|
| Medium |
[E-Book] |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Place of production, publication, distribution, manufacture |
New York : |
| Name of producer, publisher, distributor, manufacturer |
Nova Biomedical, |
| Date of production, publication, distribution, manufacture, or copyright notice |
[2012] |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Physical description |
1 online resource. |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text |
| Content type code |
txt |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
computer |
| Media type code |
c |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
online resource |
| Carrier type code |
cr |
| Source |
rdacarrier |
| 490 1# - SERIES TITLE |
|---|
| Series statement |
Nephrology research and clinical developments |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references and index. |
| 505 0# - CONTENTS |
|---|
| Contents |
NEPHROPATHY: DIAGNOSIS AND TREATMENT; NEPHROPATHY: DIAGNOSIS AND TREATMENT; Library of Congress Cataloging-in-Publication Data; CONTENTS; PREFACE; Chapter 1: ACUTE KIDNEY INJURY; INTRODUCTION; AKI DEFINITION; AKI ETIOLOGY AND PATHOBIOLOGY; Prerenal Azotemia; Ischemic and Nephrotoxic Acute Tubular Necrosis; Contrast Induced Nephropathy (CIN) (See also Chapter 16); Drug Induced AKI; Amininoglycoside Nephrotoxicity; Tumor Lysis; Rhabdomyolysis; Cast Nephropathy and AKI; Septic AKI; Early Biomarkers of AKI; Serum Biomarkers; Serum Cystatin C; Pro-Atrial Natriuretic Polypeptide (Proanp) |
| 505 8# - CONTENTS |
|---|
| Contents |
Urinary BiomarkersNeutrophil Gelatinase Associated Lipocalin (NGAL); Kidney Injury Molecule -- 1 (KIM-1); Urinary Na+ -- H+ Exchanger Isoform 3 (NHE3); Urinary Cytokines; Cysteine Rich Protein 61 (Cyr61, CCN1); Glutathione S-Transferases (GSTs); Hepatocyte Growth Factor (HGF); Epidermal Growth Factor (EGF); Insulin Like Growth Factor -- 1 (IGF-1); AKI SECONDARY TO ACUTE TUBULOINTERSTITAL NEPHRITIS; AKI SECONDARY TO ACUTE GLOMEURLONEPHRITISAND VASCULITIS; AKI FROM ACUTE OBSTRUCTION; GPAKI IN HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION; TROPICAL INFECTIONS AND AKI; Falciparum Malaria. |
| 505 8# - CONTENTS |
|---|
| Contents |
LeptospirosisMANAGEMENT OF AKI; Fluid Resuscitation in AKI; Loop Diuretics in AKI; Role of Dopamine and Fenoldapam in AKI; RENAL REPLACEMENT THERAPY IN AKI; Vascular Access for Renal Replacement Therapy; Conventional Intermittent Hemodialysis (IHD); Dialysis Dose in IHD; Continuous Renal Replacement Therapy (CRRT); Comparing IHD Versus CRRT for AKI Support; Dialysis Dosing in CRRT; Sustained Low Efficiency Dilaysis; CONCLUSION; REFERENCES; Chapter 2: IDENTIFICATION AND EVALUATION OFPATIENTS WITH CHRONIC KIDNEY DISEASE; INTRODUCTION; DEFINING CHRONIC KIDNEY DISEASE. |
| 505 8# - CONTENTS |
|---|
| Contents |
CAUSES OF CHRONIC KIDNEY DISEASEDiseases of the Arterial Supply; Glomerular Diseases; Tubulo-Interstitial Diseases; Obstructive Uropathy; The Diagnosis of 'CKD -- Cause Unknown'; Relative Incidences of Causes of CKD; MEASURING KIDNEY FUNCTION; MDRD Formula to Estimate GFR; CKD-EPI Formulae; Cockcroft Gault Formula; Cystatin C; EXAMINATION OF THE URINE; Urinalysis; Protein; Haem; Urine Microscopy; Laboratory Quantification of Proteinuria; PRESENTATION OF CKD; Asymptomatic Reduced eGFR and/or Proteinuria; Nephrotic Syndrome; Nephritic Syndrome; Isolated Non-Visible Haematuria. |
| 505 8# - CONTENTS |
|---|
| Contents |
CKD Following Acute Kidney InjuryAdvanced Uraemia; EVALUATION OF THE PATIENT WITH CKD; History; Examination; Kidney Imaging (See also Chapter 3); Specific Blood Tests; Kidney Biopsy (See also Chapter 6); GRADING/CLASSIFICATION OF CKD; REFERENCES; Chapter 3: IMAGING IN KIDNEY DISEASE; INTRODUCTION; IMAGING TECHNIQUES; Ultrasound; Computed Tomography; Magnetic Resonance Imaging; Renal Scintigraphy; Plain Radiography; Intravenous Urography; The Impact of Obesity on Medical Imaging; Image Guided Renal Biopsy; ACUTE KIDNEY INJURY (AKI); Introduction; Pre-Renal AKI; Post-Renal AKI; Intrinsic AKI. |
| 590 ## - LOCAL NOTE (RLIN) |
|---|
| Local note |
Master record variable field(s) change: 050, 082, 650 |
| 650 #0 - SUBJECT HEADINGS |
|---|
| Subject term |
Kidneys |
| General subdivision |
Diseases. |
| 650 #2 - SUBJECT HEADINGS |
|---|
| Subject term |
Kidney Diseases |
| General subdivision |
diagnosis. |
| 650 #2 - SUBJECT HEADINGS |
|---|
| Subject term |
Kidney Diseases |
| General subdivision |
therapy. |
| 700 1# - ADDED PERSONAL NAME |
|---|
| Added personal author |
Fava, Stephen, |
| Relator term |
editor of compilation. |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE |
|---|
| Uniform title |
Nephrology research and clinical developments series. |
| 856 40 - ONLINE RESOURCE |
|---|
| Uniform Resource Identifier |
<a href="https://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=541277">https://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=541277</a> |
| Link text |
Kingston Hospital NHS Foundation Trust OpenAthens account holders click here for access |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Suppress in OPAC |
Do not Suppress in OPAC |
| 588 ## - SOURCE OF DESCRIPTION NOTE |
|---|
| Source of description note |
Description based on print version record. |
| 938 ## - |
|---|
| -- |
YBP Library Services |
| -- |
YANK |
| -- |
9370070 |
| 938 ## - |
|---|
| -- |
EBSCOhost |
| -- |
EBSC |
| -- |
541277 |
| 938 ## - |
|---|
| -- |
ebrary |
| -- |
EBRY |
| -- |
ebr10681186 |
| 938 ## - |
|---|
| -- |
ProQuest Ebook Central |
| -- |
EBLB |
| -- |
EBL3020986 |
| 994 ## - |
|---|
| -- |
92 |
| -- |
N$T |